Back to Research Hub
Corcept Therapeutics Incorporated
CORT
$89.72+0.15 (+0.17%)
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States.
StreetsValue research for Corcept Therapeutics Incorporated (CORT)
Members get the full report for Corcept Therapeutics Incorporated: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.